Author

K. R. Franzenburg

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Patient and Healthcare Professional Attitudes and Trial Experiences with a Subcutaneous Long-Acting Injectable Olanzapine (TV-44749) for Schizophrenia Treatment.

INTRODUCTION Long-acting injectable (LAI) antipsychotics improve schizophrenia treatment adherence compared with oral antipsychotics but remain underused. TV-44749 is an innovative, once-monthly, subcutaneous (SC) LAI olanzapine designed to provide sustained efficacy through controlled olanzapine release over the month...

Andrew J. Cutler, Alma Gonzalez, M. Suett et al. · Advances in Therapy · 0 citations

Open access Sep 2026

Factors associated with rates of long-acting injectable antipsychotic use for schizophrenia: A subgroup analysis of the multinational ADVANCE study.

INTRODUCTION Long-acting injectable antipsychotics (LAIs) are underused despite known benefits. This subgroup analysis from the Attitudes DriVing regional differences in LAI ANtipsychotic utilization for schizophrenia among healthcare professionals (HCPs), patients, and CaregivErs (ADVANCE) study aimed to understand fa...

K. R. Franzenburg, Rolf T. Hansen, M. Suett et al. · Psychiatry Research · 0 citations